158 related articles for article (PubMed ID: 37778613)
1. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light compared to neuron-specific enolase as a predictor of unfavourable outcome after out-of-hospital cardiac arrest.
Wihersaari L; Reinikainen M; Furlan R; Mandelli A; Vaahersalo J; Kurola J; Tiainen M; Pettilä V; Bendel S; Varpula T; Latini R; Ristagno G; Skrifvars MB
Resuscitation; 2022 May; 174():1-8. PubMed ID: 35245610
[TBL] [Abstract][Full Text] [Related]
3. GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest: A post hoc analysis of the COMACARE trial.
Humaloja J; Lähde M; Ashton NJ; Reinikainen M; Hästbacka J; Jakkula P; Friberg H; Cronberg T; Pettilä V; Blennow K; Zetterberg H; Skrifvars MB;
Resuscitation; 2022 Jan; 170():141-149. PubMed ID: 34863908
[TBL] [Abstract][Full Text] [Related]
4. Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest.
Moseby-Knappe M; Mattsson-Carlgren N; Stammet P; Backman S; Blennow K; Dankiewicz J; Friberg H; Hassager C; Horn J; Kjaergaard J; Lilja G; Rylander C; Ullén S; Undén J; Westhall E; Wise MP; Zetterberg H; Nielsen N; Cronberg T
Intensive Care Med; 2021 Sep; 47(9):984-994. PubMed ID: 34417831
[TBL] [Abstract][Full Text] [Related]
5. Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest.
Levin H; Lybeck A; Frigyesi A; Arctaedius I; Thorgeirsdóttir B; Annborn M; Moseby-Knappe M; Nielsen N; Cronberg T; Ashton NJ; Zetterberg H; Blennow K; Friberg H; Mattsson-Carlgren N
Crit Care; 2023 Feb; 27(1):74. PubMed ID: 36829239
[TBL] [Abstract][Full Text] [Related]
6. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial.
Wihersaari L; Ashton NJ; Reinikainen M; Jakkula P; Pettilä V; Hästbacka J; Tiainen M; Loisa P; Friberg H; Cronberg T; Blennow K; Zetterberg H; Skrifvars MB;
Intensive Care Med; 2021 Jan; 47(1):39-48. PubMed ID: 32852582
[TBL] [Abstract][Full Text] [Related]
8. Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients.
Ebner F; Moseby-Knappe M; Mattsson-Carlgren N; Lilja G; Dragancea I; Undén J; Friberg H; Erlinge D; Kjaergaard J; Hassager C; Wise MP; Kuiper M; Stammet P; Wanscher M; Horn J; Ullén S; Cronberg T; Nielsen N
Resuscitation; 2020 Sep; 154():61-68. PubMed ID: 32445783
[TBL] [Abstract][Full Text] [Related]
9. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
[TBL] [Abstract][Full Text] [Related]
10. Predicting neurological outcome after out-of-hospital cardiac arrest with cumulative information; development and internal validation of an artificial neural network algorithm.
Andersson P; Johnsson J; Björnsson O; Cronberg T; Hassager C; Zetterberg H; Stammet P; Undén J; Kjaergaard J; Friberg H; Blennow K; Lilja G; Wise MP; Dankiewicz J; Nielsen N; Frigyesi A
Crit Care; 2021 Feb; 25(1):83. PubMed ID: 33632280
[TBL] [Abstract][Full Text] [Related]
11. Predicting poor neurological outcomes following out-of-hospital cardiac arrest using neuron-specific enolase and neurofilament light chain in patients with and without haemolysis.
Abdi Isse Y; Frikke-Schmidt R; Wiberg S; Grand J; Obling LER; Meyer ASP; Kjaergaard J; Hassager C; Meyer MAS
Eur Heart J Open; 2023 Jul; 3(4):oead078. PubMed ID: 37646044
[TBL] [Abstract][Full Text] [Related]
12. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
13. Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
Lin X; Lu T; Deng H; Liu C; Yang Y; Chen T; Qin Y; Xie X; Xie Z; Liu M; Ouyang M; Li S; Song Y; Zhong N; Qiu W; Zhou C
J Neurol; 2022 Feb; 269(2):815-823. PubMed ID: 34283286
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
15. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
[TBL] [Abstract][Full Text] [Related]
16. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
[TBL] [Abstract][Full Text] [Related]
17. Absolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest.
Adler C; Onur OA; Braumann S; Gramespacher H; Bittner S; Falk S; Fink GR; Baldus S; Warnke C
J Neurol; 2022 Mar; 269(3):1530-1537. PubMed ID: 34328545
[TBL] [Abstract][Full Text] [Related]
18. Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.
Camara-Lemarroy C; Silva C; Gohill J; Yong VW; Koch M
Eur J Neurol; 2023 Jan; 30(1):187-194. PubMed ID: 36214614
[TBL] [Abstract][Full Text] [Related]
19. Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.
Moseby-Knappe M; Mattsson N; Nielsen N; Zetterberg H; Blennow K; Dankiewicz J; Dragancea I; Friberg H; Lilja G; Insel PS; Rylander C; Westhall E; Kjaergaard J; Wise MP; Hassager C; Kuiper MA; Stammet P; Wanscher MCJ; Wetterslev J; Erlinge D; Horn J; Pellis T; Cronberg T
JAMA Neurol; 2019 Jan; 76(1):64-71. PubMed ID: 30383090
[TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study.
Hunziker S; Quinto A; Ramin-Wright M; Becker C; Beck K; Vincent A; Tisljar K; Disanto G; Benkert P; Leppert D; Pargger H; Marsch S; Raoul Sutter ; Peters N; Kuhle J
Crit Care; 2021 Jan; 25(1):32. PubMed ID: 33472689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
